Case Study

When Every Sample Is A Life Trusted To Our Care: How CRL Automated Their Assay And Scale Throughput

GettyImages-862197296-lab-team-test tube

Faced with the onset of the COVID-19 pandemic in the US in February 2020, Clinical Reference Labs (CRL) realized that they had the resources and capabilities to make a difference, and set out to develop a qPCR-based SARS-CoV-2 assay that could use self-collected samples.

In just a few months, they identified saliva as their desired sample type, developed an assay, and obtained Emergency Use Authorization from the FDA.

Discover how Artel® technology played a critical role in Clinical Reference Labs' exceptionally fast development and scale-up of a saliva-based SARS-CoV-2 assay to meet the unprecedented testing need.

access the Case Study!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Hydrocarbon Online? Subscribe today.

Subscribe to Hydrocarbon Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Hydrocarbon Online